Ric Peterson

Ric Peterson currently serves as Chief Financial Officer at Turn Biotechnologies since October 2022 and has been a member of the Board of Directors and Audit Committee Chair at Universal Insurance Holdings since June 2014. Previous roles include Chief Financial Officer at Botanix Pharmaceuticals (August 2019 - May 2020), Dermavant Sciences (March 2018 - February 2019), Sienna Biopharmaceuticals (March 2017 - March 2018), and Novan, Inc. (September 2015 - March 2017), where responsibilities encompassed accounting, finance, and investor relations. Ric Peterson held the position of EVP, Chief Financial Officer, and Treasurer at Medicis from June 1995 to December 2012, overseeing a substantial balance sheet and significant sales figures. Initial career experience includes working as an auditor at PwC from December 1992 to June 1995. Ric Peterson earned a Bachelor of Science in Accountancy from Arizona State University in 1992.